Yasuo Kabeshima
Keio University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasuo Kabeshima.
Surgical Endoscopy and Other Interventional Techniques | 2003
Hirotoshi Hasegawa; Yasuo Kabeshima; Masazumi Watanabe; Seiichiro Yamamoto; Masaki Kitajima
Background: After confirming a favorable outcome of laparoscopic surgery for early colorectal cancer, we conducted a randomized controlled trial to compare short-term outcomes of laparoscopic and open colectomy for advanced colorectal cancer. Methods: Fifty-nine patients with T2 or T3 colorectal cancer were randomized to undergo laparoscopic (n = 29) or open (n = 30) colectomy. Median follow-up was 20 months (range, 6–34 months). Results: Operative time was longer (p <0.0001) and blood loss (p = 0.0034) and postoperative analgesic requirement were less in the laparoscopic group than in the open group. An earlier return of bowel motility and earlier discharge from the hospital (p = 0.0164) were observed after laparoscopic surgery. Serum C-reactive protein levels on postoperative days 1 (p <0.0001) and 4 (p = 0.0039) were lower in the laparoscopic group than in the open group. Postoperative complications did not differ between the two groups. Conclusion: Laparoscopic surgery for advanced colorectal cancer is feasible, with favorable short-term outcome.
Diseases of The Colon & Rectum | 2002
Takeyoshi Yamauchi; Masahiko Watanabe; Tetsuro Kubota; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Yasuo Kabeshima; Kyoko Yorozuya; Kentaro Yamamoto; Makio Mukai; Masaki Kitajima
PURPOSE: Epidemiologic studies indicate that the use of nonsteroidal anti-inflammatory drugs, which inhibit cyclooxygenase activity, reduce the risk of colorectal cancer. In addition, several studies demonstrate increased expression of cyclooxygenase-2 in human colorectal cancer tissues. However, the role of cyclooxygenase-2 expression in colorectal cancer has not yet been fully established. The aim of this study was to clarify the clinicopathologic significance of cyclooxygenase-2 expression in human colorectal cancer. METHODS: A total of 232 surgically resected colorectal cancer specimens were analyzed immunohistochemically with the use of a murine anti-human cyclooxygenase-2 monoclonal antibody. Cyclooxygenase-2 expression was then compared with clinicopathologic background and survival outcome. RESULTS: Cyclooxygenase-2 was expressed in the cytoplasm of the cancer cells but not in normal epithelium. Cyclooxygenase-2 expression was noted in 71.6 percent (166/232) of the cancer patients and correlated significantly with histologic type (P = 0.033), depth of invasion (P = 0.016), pathologic stage (P = 0.020), and metachronous liver metastasis (P = 0.001). Multivariate analysis for factors associated with metachronous liver metastasis showed that cyclooxygenase-2 expression was one of the independent risk factors, second only to lymph node metastasis. Patients with cyclooxygenase-2 expression showed a significantly poorer outcome compared with those without cyclooxygenase-2 expression (P = 0.002). CONCLUSION: Cyclooxygenase-2 expression in the primary lesion may be a useful marker for evaluating prognosis and liver metastasis in patients with colorectal cancer.
Journal of Gastroenterology | 2002
Takeyoshi Yamauchi; Masahiko Watanabe; Hirotoshi Hasegawa; Seiichiro Yamamoto; Takashi Endo; Yasuo Kabeshima; Kyoko Yorozuya; Kentaro Yamamoto; Masaki Kitajima
We report the case of a 76-year-old woman with a flat elevated lesion (laterally spreading tumor; LST) in the transverse colon that had been identified 2 years before the current presentation. Pathologically, the lesion had been diagnosed as a serrated adenoma with severe dysplasia. The patient had refused endoscopic resection because she was afraid of the risk of colonic perforation; she did not come to follow-up until 2 years after the diagnosis, when she had advanced colon cancer in the transverse colon where the LST had been detected. Histopathological examination confirmed a poorly differentiated adenocarcinoma with no adenomatous component such as had been found in the LST lesion.
Journal of Pediatric Surgery | 2011
Shintaro Shibutani; Hideaki Obara; Shigeshi Ono; Yasuo Kabeshima; Hirofumi Kawakubo; Masaya Shito; Toshihiro Kakefuda; Tai Omori; Hiroaki Sato; Yoshiaki Narimatsu; Yuko Kitagawa
A 14-year-old girl had massive bleeding from a Dieulafoy lesion of the ileum. A preoperative dynamic computed tomography scan detected the point of bleeding. Selective arteriography with embolization using microcoils could not stop the bleeding, but the microcoils were useful as markers of the location of the bleeding point. The position of the microcoils was confirmed by intraoperative fluoroscopy. A partial resection of the ileum that included the lesion was performed. The pathologic finding was Dieulafoy lesion of the ileum. Dieulafoy lesion is a rare condition that usually presents in the stomach. Dieulafoy lesion of the ileum is extraordinarily rare, and to our knowledge, this is only the second case report of an ileal lesion in a child.
Anticancer Research | 2002
Yasuo Kabeshima; Tetsuro Kubota; Masahiko Watanabe; Hirotoshi Hasegawa; Toshiharu Furukawa; Masaki Kitajima
Pediatric Dermatology | 2010
Satoru Morita; Kazuo Koyanagi; Motomu Tanaka; Susumu Watada; Kyoko Yorozuya; Sojun Hoshimoto; Yasuo Kabeshima; Masaya Shito; Koichi Aiura; Hitoshi Sugiura; Toshihiro Kakefuda; Tai Omori
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2001
Yasuo Kabeshima; Masahiko Watanabe; Hirotoshi Hasegawa; Seiichiro Yamamoto; Takashi Endo; Takeyoshi Yamauchi; Kyoko Yorozuya; Yumikko Sauchi; Masaki Kitajima
Anticancer Research | 2002
Yasuo Kabeshima; Tetsuro Kubota; Masahiko Watanabe; Yoshiro Saikawa; Hideki Nishibori; Hirotoshi Hasegawa; Masaki Kitajima
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2001
Hirotoshi Hasegawa; Masahiko Watanabe; Kentaro Yamamoto; Seiichiro Yamamoto; Yoshiyuki Ishii; Takashi Endo; Takeyoshi Yamauchi; Yasuo Kabeshima; Kyoko Yorozuya; Masaki Kitajima
Pediatric Dermatology | 2014
Kentaro Inoue; Koichi Aiura; Masaya Shito; Sojun Hoshimoto; Yasuo Kabeshima; Kazuo Koyanagi; Ariizumi Ken; Hanae Takagi; Hironao Tamai; Rie Irie; Hitoshi Sugiura